KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Current Assets (2016 - 2026)

Medtronic's Current Assets history spans 12 years, with the latest figure at $24.1 billion for Q1 2026.

  • For Q1 2026, Current Assets rose 6.92% year-over-year to $24.1 billion; the TTM value through Jan 2026 reached $24.1 billion, up 6.92%, while the annual FY2025 figure was $23.8 billion, 8.57% up from the prior year.
  • Current Assets for Q1 2026 was $24.1 billion at Medtronic, roughly flat from $24.0 billion in the prior quarter.
  • Across five years, Current Assets topped out at $25.4 billion in Q4 2022 and bottomed at $21.7 billion in Q2 2023.
  • The 5-year median for Current Assets is $22.5 billion (2024), against an average of $23.0 billion.
  • The largest annual shift saw Current Assets rose 11.73% in 2022 before it fell 13.06% in 2023.
  • A 5-year view of Current Assets shows it stood at $25.4 billion in 2022, then dropped by 13.06% to $22.1 billion in 2023, then grew by 1.62% to $22.4 billion in 2024, then grew by 6.94% to $24.0 billion in 2025, then rose by 0.31% to $24.1 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Current Assets are $24.1 billion (Q1 2026), $24.0 billion (Q4 2025), and $23.2 billion (Q3 2025).